These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 35068390

  • 21. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
    Olaniyan HS, Briscoe C, Muhongo M, Pascoal R, Armando A, Santos B, McGann PT.
    Blood Adv; 2023 Oct 10; 7(19):5860-5867. PubMed ID: 37399450
    [Abstract] [Full Text] [Related]

  • 22. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB.
    Lancet Haematol; 2020 Jul 10; 7(7):e534-e540. PubMed ID: 32589979
    [Abstract] [Full Text] [Related]

  • 23. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
    Nnodu O, Isa H, Nwegbu M, Ohiaeri C, Adegoke S, Chianumba R, Ugwu N, Brown B, Olaniyi J, Okocha E, Lawson J, Hassan AA, Diaku-Akinwumi I, Madu A, Ezenwosu O, Tanko Y, Kangiwa U, Girei A, Israel-Aina Y, Ladu A, Egbuzu P, Abjah U, Okolo A, Akbulut-Jeradi N, Fernandez M, Piel FB, Adekile A.
    Blood Cells Mol Dis; 2019 Sep 10; 78():22-28. PubMed ID: 30773433
    [Abstract] [Full Text] [Related]

  • 24. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
    Oluwole EO, Adeyemo TA, Osanyin GE, Odukoya OO, Kanki PJ, Afolabi BB.
    PLoS One; 2020 Sep 10; 15(12):e0242861. PubMed ID: 33270733
    [Abstract] [Full Text] [Related]

  • 25. Validity of simple clinical and biological parameters as screening tool for sickle cell anemia for referral to tertiary center in highly resource constraints.
    Kadima BT, Gini-Ehungu JL, Mbutiwi FIN, Bahati JT, Aloni MN.
    J Clin Lab Anal; 2017 Nov 10; 31(6):. PubMed ID: 28094443
    [Abstract] [Full Text] [Related]

  • 26. DNA testing for sickle cell anemia in Africa: Implementation choices for the Democratic Republic of Congo.
    Ngole M, Race V, Mbayabo G, Lumbala P, Songo C, Lukusa PT, Devriendt K, Matthijs G, Lumaka A.
    J Clin Lab Anal; 2022 May 10; 36(5):e24398. PubMed ID: 35405024
    [Abstract] [Full Text] [Related]

  • 27. Improvement of SCD morbimortality in children: experience in a remote area of an African country.
    Mbiya BM, Kalombo DK, Mukendi YN, Daubie V, Mpoyi JK, Biboyi PM, Disashi GT, Gulbis B.
    BMC Health Serv Res; 2021 Apr 01; 21(1):294. PubMed ID: 33794895
    [Abstract] [Full Text] [Related]

  • 28. The burden of sickle cell disease in Cape Town.
    Wonkam A, Ponde C, Nicholson N, Fieggen K, Ramessar R, Davidson A.
    S Afr Med J; 2012 Jun 28; 102(9):752-4. PubMed ID: 22958698
    [Abstract] [Full Text] [Related]

  • 29. The Ugandan sickle Pan-African research consortium registry: design, development, and lessons.
    Nsubuga M, Mutegeki H, Jjingo D, Munube D, Namazzi R, Opoka R, Kasirye P, Ndeezi G, Hume H, Mupere E, Kebirungi G, Birungi I, Morrice J, Jonas M, Nembaware V, Wonkam A, Makani J, Kiguli S.
    BMC Med Inform Decis Mak; 2024 Jul 29; 24(1):212. PubMed ID: 39075479
    [Abstract] [Full Text] [Related]

  • 30. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB, Awad S, Happich M, Muckenthaler L, Lindner M, Gramer G, Okun JG, Hoffmann GF, Bruckner T, Muckenthaler MU, Kulozik AE.
    Ann Hematol; 2016 Feb 29; 95(3):397-402. PubMed ID: 26658910
    [Abstract] [Full Text] [Related]

  • 31. Unveiling mortality risk factors in paediatric sickle cell disease patients during acute crises in the Democratic Republic of the Congo.
    Boma PM, Ngimbi SL, Kindundu JM, Wela JI, Ngoie NL, Ngwamah VM, Tshiswaka SM, Monga JK, Panda JM, Bonnechère B.
    Blood Cells Mol Dis; 2024 Mar 29; 105():102828. PubMed ID: 38266515
    [Abstract] [Full Text] [Related]

  • 32. Students' knowledge on sickle cell disease in Kisangani, Democratic Republic of the Congo.
    Kambale-Kombi P, Marini Djang'eing'a R, Alworong'a Opara JP, Tonen-Wolyec S, Kayembe Tshilumba C, Batina-Agasa S.
    Hematology; 2020 Dec 29; 25(1):91-94. PubMed ID: 32070266
    [Abstract] [Full Text] [Related]

  • 33. Comorbidity of sickle cell trait and albinism: a cross-sectional survey in the Democratic Republic of the Congo.
    Kambale-Kombi P, Djang'eing'a RM, Alworong'a Opara JP, Wa Inena GI, Falay Sadiki D, Boemer F, Bours V, Tshilumba CK, Batina-Agasa S.
    Pan Afr Med J; 2020 Dec 29; 35():127. PubMed ID: 32637025
    [Abstract] [Full Text] [Related]

  • 34. [Neonatal screening for sickle cell disease at the Nice University Hospital: the last 8 years].
    Berthet S, Monpoux F, Soummer AM, Bérard E, Sarles J, Badens C.
    Arch Pediatr; 2010 Dec 29; 17(12):1652-6. PubMed ID: 21087846
    [Abstract] [Full Text] [Related]

  • 35. Sustainability of newborn screening for sickle cell disease in resource-poor countries: A systematic review.
    Okeke CO, Okeke C, Asala S, Ofakunrin AOD, Ufelle S, Nnodu OE.
    PLoS One; 2024 Dec 29; 19(9):e0305110. PubMed ID: 39241049
    [Abstract] [Full Text] [Related]

  • 36. Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease.
    Diallo DA, Guindo A.
    Curr Opin Hematol; 2014 May 29; 21(3):210-4. PubMed ID: 24613937
    [Abstract] [Full Text] [Related]

  • 37. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S.
    Int J Lab Hematol; 2022 Oct 29; 44(5):959-965. PubMed ID: 35775883
    [Abstract] [Full Text] [Related]

  • 38. Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019.
    Hernandez AG, Kiyaga C, Howard TA, Ssewanyana I, Ndeezi G, Aceng JR, Ware RE.
    Trop Med Int Health; 2021 Jan 29; 26(1):23-32. PubMed ID: 33151598
    [Abstract] [Full Text] [Related]

  • 39. Knowledge and practices of sickle cell disease among healthcare providers in Kinshasa, Democratic Republic of the Congo.
    Ngonde AM, Fina JL, Burgueno E, Lukanu PN.
    Afr J Prim Health Care Fam Med; 2024 Feb 15; 16(1):e1-e8. PubMed ID: 38426772
    [Abstract] [Full Text] [Related]

  • 40. The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology.
    Green NS, Zapfel A, Nnodu OE, Franklin P, Tubman VN, Chirande L, Kiyaga C, Chunda-Liyoka C, Awuonda B, Ohene-Frempong K, Inusa BPD, Ware RE, Odame I, Ambrose EE, Dogara LG, Oron AP, Willett C, Thompson AA, Berliner N, Coetzer TL, Novelli EM.
    Blood Adv; 2022 Dec 27; 6(24):6187-6197. PubMed ID: 36264096
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.